Cited by 110Cancer survivorship and careEconomic and Financial Impacts of CancerFrailty in Older Adults

Symptom Prevalence in Lung and Colorectal Cancer Patients

Open access
Walling, Anne M., Weeks, Jane C., Kahn, Katherine L., Tisnado, Diana, Keating, Nancy L., Dy, Sydney M., Arora, Neeraj K., Mack, Jennifer W. +2 more·2015·Journal of Pain and Symptom Management

Abstract

Context Relatively few data are available about symptoms among cancer patients.Objectives To describe the prevalence and severity of symptoms among a large, representative cohort of newly diagnosed cancer patients.Methods We collected survey data about symptoms (pain, fatigue, depression, nausea/vomiting, cough, dyspnea, and diarrhea) from 5422 patients with incident lung and colorectal cancer from the diverse, nationally representative Cancer Care Outcomes Research and Surveillance Consortium cohort. We described the prevalence of any symptoms and moderate/severe symptoms approximately four to six months after diagnosis. We used logistic regression to identify patient and clinical characteristics associated with symptoms, and calculated adjusted proportions of patients with symptoms.Results In total, 5067 (93.5%) patients reported at least one symptom in the four weeks before their survey, with 51% reporting at least one moderate/severe symptom. Lung cancer patients reported more symptoms than colorectal cancer patients. Patients who received treatment or had more comorbidities were more likely to report symptoms. For example, after adjustment, patients who received chemotherapy during the six weeks before the survey were more likely than others to report at least one symptom (97.3% vs. 90.8%, P<0.001), and at least one moderate/severe symptom (56.8% vs. 46.2%, P<0.001). After adjustment, early- vs. late-stage patients did not differ in reports of at least one symptom (93.6% vs. 93.4%, P=0.853) and differed only slightly in reports of at least one moderate/severe symptom (53.3% vs. 49.6%, P=0.009).Conclusion Most recently diagnosed lung and colorectal cancer patients have cancer-related symptoms regardless of stage, and more than half have at least one moderate/severe symptom.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpainsymman.2014.06.003

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many advanced cancer patients have symptoms that interfere with functioning.

    “Many advanced cancer patients have symptoms that interfere with functioning.1–3”

    From Symptom experiences in advanced cancer: Relationships to acceptance and commitment therapy constructs (2021) · cites this paper as [3]

    The Results (Patient Factors Associated with Symptom Prevalence; page not provided) report that 49.6% of late-stage lung and colorectal cancer patients had at least one moderate or severe symptom, supporting the claim that many advanced cancer patients have symptoms. The paper measures symptom severity, not whether those symptoms interfere with functioning, so that part is not established by this source. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [37]He Y Zaslavsky AM Harrington DP Imputation in a multiformat and multiwave survey of cancer care Proceedings in Health Policy Statistics American Statistical Association 2007 1541 1549

Cited by

Sorted by citations

Authors
Walling, A. M., Weeks, J. C., Kahn, K. L., Tisnado, D., Keating, N. L., Dy, S. M., Arora, N. K., Mack, J. W., Pantoja, P. M., & Malin, J. L.
Affiliations
  • RAND Corporation (US)
  • Harvard University (US)
  • University of California, Los Angeles (US)
  • Brigham and Women's Hospital (US)
  • Johns Hopkins University (US)
  • National Cancer Institute (US)
  • VA Greater Los Angeles Healthcare System (US)
Corresponding author
Walling, Anne M.
Venue
Journal of Pain and Symptom Management
Publisher
Elsevier BV
Published
2015-02
Volume
49
Issue
2
Pages
192-202
ISSN
0885-3924 (ISSN-L)
OpenAlex
W2059521335
Cited by
110
References
54
Citations by year
2026: 8 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 13 · 2021: 14 · 2020: 11 · 2019: 9 · 2018: 10 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 3
FWCI
3.38
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain and Symptom Management (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Cancer Society (119663-RSG-10-176-01-PCSM)
  • National Cancer Institute (U01 CA093344)
  • Harvard Medical School and Northern California Cancer Center (U01 CA093324)
  • Dana-Farber Cancer Institute and Cancer Research Network (U01 CA093332)
  • RAND Corporation
  • University of California (U01 CA093348)
  • University of Alabama (U01 CA093329)
  • University of Iowa (U01 CA093339)
  • University of North Carolina (U01 CA093326)
  • Durham VA Medical Center (U01 CDA093344 (MOU), HARQ 03-438MO-03)
  • National Institutes of Health (R011CA164021-01A1)
  • NIH
  • National Center for Advancing Translational Sciences
  • UCLA CTSI (UL1TR000123)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Keywords
cancer symptoms, symptom prevalence, lung cancer, colorectal cancer, newly diagnosed cancer, chemotherapy, comorbidities, tumor stage, symptom severity, cancer care outcomes
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Humans, Lung Neoplasms, Male, Middle Aged, Surveys and Questionnaires, Severity of Illness Index, United States, Colorectal Neoplasms, Cohort Studies, Comorbidity, Prevalence, Multivariate Analysis, Logistic Models, Disease Progression, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review